Drug Discovery and Development V 2 – Drug elopment
Seiten
2007
John Wiley & Sons Inc (Hersteller)
978-0-470-08522-6 (ISBN)
John Wiley & Sons Inc (Hersteller)
978-0-470-08522-6 (ISBN)
- Keine Verlagsinformationen verfügbar
- Artikel merken
Provides an account of the entire sequence of operations involved in discovering a drug through the actual delivery of the drug to clinicians and medical practitioners.
This "Volume 2: Drug Development" thoroughly describes optimizing the synthetic route; manufacturing, outsourcing, and marketing the drug, including coloring; and developing delivery methods.
This "Volume 2: Drug Development" thoroughly describes optimizing the synthetic route; manufacturing, outsourcing, and marketing the drug, including coloring; and developing delivery methods.
Mukund S. Chorghade, PHD, is President of Chorghade Enterprises, Inc., a firm based in Natick, Massachusetts, that provides consultations to major pharmaceutical companieson collaborations with worldwide academic, government, and industrial laboratories; European technology-based companies; process reengineering; and project management of technology transfer.
| Verlagsort | New York |
|---|---|
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Pharmakologie / Pharmakotherapie |
| ISBN-10 | 0-470-08522-3 / 0470085223 |
| ISBN-13 | 978-0-470-08522-6 / 9780470085226 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
